Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial

Fifty healthy women, aged 18-39 years with no known risk of ovarian hyperstimulation were treated with 100 or 150 ug corifollitropin alfa (dependent on body weight) in a long GnRH agonist protocol. A these doses, corifollitropin alfa initiated and supported growth of a large cohort of follicles during the first week of ovarian stimulation.

Publication year:2010

Keywords:corifolitropin alfa